Napajen Pharma

Napajen Pharma

Napajen Pharma

A pioneer in immunomodulation by cell specific delivery of oligonucleotide drugs to antigen presenting cells completing IND enabling studies for a groundbreaking antiGVHD drug for hematopoietic stem cell transplantation in hematological cancers.
Founded
2005
Raised
$12.4M
Follow us
Alexa global traffic share
Latest funding
$12,400,000
Venture capital (Series C) - 2019
Mitsui & Co. Global Investment INCJ P&D Directions Inc.
Team Size
10+
Employees
$12,400,000 Venture capital (Series C)
FinSMEs

NapaJen Pharma Closes $12.4M Series C Financing